Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study

Henriette Thisted Horsdal, Michael Eriksen Benros, Ole Köhler-Forsberg, Jesper Krogh, Christiane Gasse

10 Citationer (Scopus)


OBJECTIVE: Schizophrenia and/or antipsychotic drug use are associated with metabolic abnormalities; however, knowledge regarding metabolic status and physician's monitoring of metabolic status at first schizophrenia diagnosis is sparse. We assessed the prevalence of monitoring for metabolic blood abnormalities and characterized the metabolic profiles in people with a first-time schizophrenia diagnosis.

METHODS: This is a population-based cross-sectional study including all adults born in Denmark after January 1, 1955, with their first schizophrenia diagnosis between 2000 and 2012 in the Central Denmark Region. Information on metabolic parameters was obtained from a clinical laboratory information system. Associations were calculated using Wilcoxon rank-sum tests, chi-square tests, logistic regression, and Spearman's correlation coefficients.

RESULTS: A total of 2,452 people with a first-time schizophrenia diagnosis were identified, of whom 1,040 (42.4%) were monitored for metabolic abnormalities. Among those monitored, 58.4% had an abnormal lipid profile and 13.8% had an abnormal glucose profile. People who had previously filled prescription(s) for antipsychotic drugs were more likely to present an abnormal lipid measure (65.7% vs 46.8%, P<0.001) and abnormal glucose profile (16.4% vs 10.1%, P=0.01).

CONCLUSION: Metabolic abnormalities are common at first schizophrenia diagnosis, particularly among those with previous antipsychotic prescription(s). Increased metabolic abnormalities already present in the early phase of schizophrenia emphasize the need for increased monitoring and management.

TidsskriftNeuropsychiatric Disease and Treatment
Sider (fra-til)621-630
Antal sider10
StatusUdgivet - 2017


Dyk ned i forskningsemnerne om 'Metabolic profile at first-time schizophrenia diagnosis: a population-based cross-sectional study'. Sammen danner de et unikt fingeraftryk.